Similarly, the studies showed that B7-H3 downregulation or inhibition can make tumor cells more sensitive to inhibitors of PI3K/Akt/mTOR and Ras/Raf/MEK signaling pathways [94]. This evidence concerns the gene AKT1 and neoplasm.